Nutrasource Diagnostics   Report issue

For profit Phase 1 Phase 2 Phase 4
Founded: Guelph ON Canada (2002)

Organization Overview

First Clinical Trial
2011
NCT01277445
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2022

Timeline

NOW
  • Now

Alternative names

Nutrasource Diagnostic Inc | Nutrasource Diagnostics Inc. | Nutrasource Pharmaceutical and Nutraceutical Services | Nutrasource Pharmaceutical and Nutraceutical Services, Inc.

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Hyperlipidemia, Familial Combined (Phase 4)

Hyperlipidemias (Phase 4)

Hyperlipoproteinemias (Phase 4)

Hyperlipoproteinemia Type V (Phase 4)

Lipidoses (Phase 4)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 13
  • # of Trial APIs: 12